Condition
Chilblains
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04455308Not ApplicableCompletedPrimary
COVID-19 and Chilblains
NCT06237517Not ApplicableCompletedPrimary
Assessment of Vasomotion of People With Idiopathic Chilblains
NCT04387955Not ApplicableCompleted
Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID)
NCT04344119Unknown
Assessment of Chilbains Occuring During Covid-19 Infection
NCT03101761CompletedPrimary
Characteristics and the Future of the City Chilblains
Showing all 5 trials